•  
  •  
  •  
  •  

2026-07-20 03:30:53

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Can Fin Homes Limited Delivers Strong Opening to FY27: Net Profit Rises 20% to ₹268 Crore Driven by Robust Disbursements
  • Punjab & Sind Bank Registers 23.05% Net Profit Surge in Q1 FY27 Powered by Robust Credit Growth and Improving Asset Quality
  • Bhansali Engineering Polymers Limited Marks Strong Start to FY27: Q1 Consolidated Net Profit Surges 42.9% to ₹65.60 Crore
  • Sangam India Ltd Reports Surge in Q1 FY27 Net Profit to ₹4,102 Lakhs
  • Rossari Biotech Limited Posts Steady Q1 FY27 Growth: Net Profit Rises to ₹350.95 Million

Keywords Selected:  Research

Research

  • HSIE Results Daily: Sun Pharmaceutical Industries, LG Electronics India, Max Healthcare Institute, Aurobindo Pharma, Prestige Estates, The Ramco Cements, TTK Prestige, Ashoka Buildcon, Repco Home Finance
  • Key Highlights from the RBI Monetary Policy Review - February 2026, by Bajaj Broking Research
  • SBI Capital Markets Report on Q2FY26 GDP - From Capex to Consumption: How Policy Initiatives Sparked a GDP Beat
  • Stylam Industries - Cementing its position in wood panels; we initiate coverage with a Buy
  • Mastek - Less dependence on UK, currency headwinds abating: retaining a Buy
  • Landmark Cars - IPO - Landmark for Premium Cars - Reliance Research
  • Top 8 Cities See 68 Land Deals for 1,656+ Acres in 9M 2022 - ANAROCK
  • ONGC Ltd - Healthy crude realization despite SAED - YES Securities
  • Reliance Research - Bajaj Auto - 2QFY23 Result Update - Strong Performance; Upgrade to BUY on Attractive Valuation
  • Acuité Ratings & Research comments on WPI - Aug'22
  • New global research from Mastercard reveals Indian consumers' payment preferences
  • Profitability of domestic broking companies moderates after a strong FY2022: ICRA
  • Comments on CPI inflation - Jun'22 - Acuité Ratings & Research
  • Reliance Research downgrades Bajaj Auto to Sell
  • India IT Services - Results Preview - Seasonally weak quarter; Supply Side Issue to Continue Exerting Margin Pressure
  • Multiplexes - Together to win - ICICI Securities
  • Acuité's forecast currently stands at 5.0% for FY23 - CPI Feb-22
  • Indian Aviation - 2022: A year of two halves - HSBC
  • HP Adhesive - IPO - Adhesive Play at Stretched Valuation - Reliance Research
  • Medplus Healthcare Services - IPO - Healthcare Retailer on Expansion Mode; Attractive Valuation - Reliance Research
  • India's GDP back to its pre-Covid levels - Acuite Ratings & Research
  • Mphasis - 2QFY22 Result Update - Growth Resiliency Continues; Raise Target Price - Reliance Research
  • Mphasis - 2QFY22 Result Update - Growth Resiliency Continues; Raise Target Price - Reliance Research
  • Indraprastha Gas - Company Update - EV vs CNG; TCO Economics Favour CNG - Reliance Research

Market Commentary

  • Bajaj Broking Research - Closing Market Commentary for 19th June 2026
  • Deal Optimism Lifts Markets, but Fresh Strikes Cloud the Outlook
  • Bajaj Broking Research - Market Closing Commentary - 20th May 2026
  • Bajaj Broking Closing Market Commentary for 25th February 2026
  • Bajaj Broking Closing Market Commentary for 24th February 2026
  • Bajaj Broking Research - Closing Market Commentary for 23rd February 2026
  • RBI MPC - Acuité Ratings & Research comments on RBI MPC - Apr'23

IPO News

  • TCS Ranks No. 1 in Customer Satisfaction in France for 5th year
  • CX Partners-backed Veeda Clinical Research gets Sebi nod for its Rs 832 crore IPO

Stock Report

  • Jaro Education Marks 17 Years of Transforming Careers, Launches #GrowWithJaro Campaign on Jaro Day
  • Hexaware Recognized Among Top Providers in Whitelane Research UK & Ireland 2026 IT Sourcing Study
  • Global Enterprises Face AI Scaling Crisis: 77% View AI as Board-Level Priority, Yet Two-Thirds Rely on Legacy Infrastructure
  • Indegene Limited recommends final dividend of Rs. 2.25
  • Indegene Reports 32.8% YoY Growth in Q4FY26, Crosses ₹1,000 Crore Quarterly Revenue
  • USFDA inspection at Rubicon Research Ltd's R&D Facility
  • Rubicon Research enters the Indian CNS formulations market with the acquisition of Arinna Lifesciences Ltd
  • Zscaler and Bharti Airtel Launch AI & Cyber Threat Research Center in India
  • SPARC announces receipt of Priority Review Voucher associated with Sezaby® Approval
  • Syngene International extends long-term research collaboration with Bristol Myers Squibb until 2035
  • Jaro Institute of Technology Management and Research Ltd declares interim dividend of Rs. 2
  • Jaro Education Renews Exclusive Partnership with Symbiosis International Deemed University
  • SPARC announces the U.S. District Court Grants Summary Judgement in Favour of SPARC for Sezaby PRV
  • Lupin Foundation Earns CRISIL's Highest VO 1A Rating for Excellence in Social Responsibility
  • Hexaware Debuts Strongly in Whitelane Research 2025 German IT Sourcing Study
  • Organic Recycling Systems Ltd signs strategic Research MoU with IIT Varanasi
  • Triveni Turbines and IISc inaugurate 'Triveni Turbines Centre of Excellence' to Drive Research in Energy Transition
  • SPARC announces consolidation of R&D laboratories and facilities
  • Lupin Bioresearch Center receives Zero Observations from U.S. FDA after Successful Inspection and Assessment
  • S&S Power Switchgear Ltd's subsidiary receives LOI for order from Egypt
  • Advagen Holdings Inc. to acquire stake in GEn1E Lifesciences Inc.
  • Indegene Strengthens Consulting Practice to Accelerate Life Sciences Transformation
  • HCLTech joins MIT Media Lab in the US to collaborate on next-gen AI research
  • Indegene announces acquisition of BioPharm to Expand AI-Driven Marketing and AdTech for Global Pharma

Industry News

  • Banks and insurers deploy AI agents to fight fraud and process applications, with plans for new roles to supervise the AI
  • Research & Ranking expands its leadership team with the appointment of Alok Arya as CMO to drive the next phase of growth
  • Religare Broking Ltd appoints Siddarth Bhamre as Research Head

Mutual Funds

  • ESGrisk.ai Launches ESG Mutual Funds Research

Latest Post

  • Can Fin Homes Limited Delivers Strong Opening to FY27: Net Profit Rises 20% to ₹268 Crore Driven by Robust Disbursements
  • Punjab & Sind Bank Registers 23.05% Net Profit Surge in Q1 FY27 Powered by Robust Credit Growth and Improving Asset Quality
  • Bhansali Engineering Polymers Limited Marks Strong Start to FY27: Q1 Consolidated Net Profit Surges 42.9% to ₹65.60 Crore
  • Sangam India Ltd Reports Surge in Q1 FY27 Net Profit to ₹4,102 Lakhs
  • Rossari Biotech Limited Posts Steady Q1 FY27 Growth: Net Profit Rises to ₹350.95 Million


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2025